https://www.selleckchem.com/pr....oducts/Mubritinib-TA
An M3 day15 bone marrow was the sole reason for escalation in three (3%) of the patients in the HR group. A lack of complete clearance of peripheral blood blasts post-prephase [HR 2.45 (1.04-5.75), p = 0.040] and a positive MRD [HR 3.00 (1.28-7.02), p = 0.011] independently predicted risk of relapse. Complete blast clearance is superior to the traditional cut-off of 1000/µL in predicting relapse. The role of a day 15 bone marrow morphology is diminished when an end of induction MRD is available.The development of an arteriove
Like
Comment
Share
